Massmedica S.A. (WSE:MSM)
Poland · Delayed Price · Currency is PLN 5.70
+0.42 (7.95%)
At close: Sep 9, 2026
Massmedica Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 31.77 | 32.22 | 32.61 | 26.37 | 24.83 | 21.61 | |
Revenue Growth | 8.71% | -1.20% | 23.68% | 6.21% | 14.89% | 18.78% |
Cost of Revenue | 18.42 | 19.39 | 19.29 | 16.6 | 15.27 | 12.86 |
Gross Profit | 13.35 | 12.83 | 13.32 | 9.77 | 9.56 | 8.75 |
Selling, General & Admin | 8.44 | 8.33 | 8.53 | 7.03 | 6.8 | 6.87 |
Other Operating Expenses | 2.68 | 2.51 | 2.94 | 1.37 | 1.28 | 0.85 |
Operating Expenses | 11.62 | 11.32 | 12.01 | 8.67 | 8.67 | 8.1 |
Operating Income | 1.73 | 1.52 | 1.32 | 1.1 | 0.88 | 0.65 |
Interest Expense | -0.58 | -0.61 | -0.42 | -0.02 | -0.02 | -0.04 |
Interest & Investment Income | 0 | - | - | 0.03 | 0.02 | - |
Currency Exchange Gain (Loss) | - | - | - | -0.02 | -0.02 | - |
Other Non Operating Income (Expenses) | -0.17 | -0.05 | -0.04 | -0.38 | -0.28 | -0.08 |
EBT Excluding Unusual Items | 0.98 | 0.86 | 0.86 | 0.7 | 0.58 | 0.53 |
Gain (Loss) on Sale of Assets | 0.01 | 0.01 | - | -0 | -0 | -0.04 |
Pretax Income | 0.99 | 0.87 | 0.86 | 0.7 | 0.58 | 0.5 |
Income Tax Expense | 0.37 | 0.33 | 0.25 | 0.19 | 0.17 | 0.15 |
Net Income | 0.62 | 0.54 | 0.6 | 0.51 | 0.41 | 0.35 |
Net Income to Common | 0.62 | 0.54 | 0.6 | 0.51 | 0.41 | 0.35 |
Net Income Growth | 63.50% | -11.23% | 17.88% | 24.52% | 17.83% | -42.06% |
Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 0.26 | 0.22 | 0.25 | 0.21 | 0.17 | 0.14 |
EPS (Diluted) | 0.26 | 0.22 | 0.25 | 0.21 | 0.17 | 0.14 |
EPS Growth | 63.50% | -11.23% | 17.88% | 24.52% | 17.83% | -42.06% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.28 | -2.16 | -0.14 | -0.57 | 0.07 | -1.69 |
Free Cash Flow Per Share | -0.94 | -0.89 | -0.06 | -0.23 | 0.03 | -0.70 |
Gross Margin | 42.03% | 39.83% | 40.86% | 37.04% | 38.50% | 40.49% |
Operating Margin | 5.46% | 4.70% | 4.04% | 4.15% | 3.56% | 3.01% |
Profit Margin | 1.95% | 1.66% | 1.85% | 1.94% | 1.66% | 1.62% |
Free Cash Flow Margin | -7.16% | -6.69% | -0.42% | -2.15% | 0.29% | -7.82% |
EBITDA | 2.23 | 1.99 | 1.86 | 1.37 | 1.47 | 1.03 |
EBITDA Margin | 7.02% | 6.19% | 5.69% | 5.20% | 5.94% | 4.77% |
D&A For EBITDA | 0.5 | 0.48 | 0.54 | 0.28 | 0.59 | 0.38 |
EBIT | 1.73 | 1.52 | 1.32 | 1.1 | 0.88 | 0.65 |
EBIT Margin | 5.46% | 4.70% | 4.04% | 4.15% | 3.56% | 3.01% |
Effective Tax Rate | 37.55% | 38.26% | 29.68% | 26.71% | 29.20% | 29.57% |
Revenue as Reported | 31.77 | 32.22 | 32.61 | - | 24.83 | 21.61 |